In this study, we present evidence demonstrating that the knockdown of CS in Mia‐Paca 2 and CRL‐2558 cell lines (Fig. 1A) results in increased sensitivity to gemcitabine, a commonly used chemotherapy drug for pancreatic cancer (Fig. 1B). This evidence concerns the gene CS and familial pancreatic carcinoma.